Epalrestat
Epalrestat CAS Mba.: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
A na-eji Epalrestat gbochie, mee ka ọ dịkwuo mma, ma gwọọ neuropathy nke dị n'akụkụ (ụfụ, mgbu), vibrational paresthesia, na ọrịa obi na-arịa ọrịa shuga. NKỌWA
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
A na-eji Epalrestat gbochie, mee ka ọ dịkwuo mma, ma gwọọ neuropathy nke dị n'akụkụ (ụfụ, mgbu), vibrational paresthesia, na ọrịa obi na-arịa ọrịa shuga. NKỌWA
| P duzie aha | Epalrestat |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319.4 |
Dee ozi gị ebe a ma zitere anyị ya
